Niu Lishu, Liang Yongchun, Niu Meie
Department of Oncology, Yancheng City No. 1 People's Hospital, Yancheng, China.
School of Nursing, Taihu University of Wuxi, Wuxi, China.
J Obstet Gynaecol Res. 2019 Jul;45(7):1319-1327. doi: 10.1111/jog.13978. Epub 2019 Apr 23.
To identify the characteristics of fear of cancer recurrence (FCR) in breast cancer patients after surgery and investigate the relationship of FCR with demographic and medical characteristics, quality of life (QOL) and social support.
The short version of the Fear of Progression Questionnaire (FoP-Q-SF), the functional assessment of cancer therapy for breast cancer (FACT-B) and the Social Support Rating Scale were administered to the 342 breast cancer patients who had undergone surgical treatment. The analysis was performed to determine potential predictors associated with FCR.
Of the 465 patients, 342 (73.5%) agreed to take part in the study. The mean age of participants was 51.46 ± 10.50 years (range, 30-81). Of the 342 participants, 92 (26.9%) cases were at Stage I, 131 (38.3%) cases at Stage II, 34 (9.9%) patients at Stage III and 85 (24.9%) patients at Stage IV. Among the 12 items of the FoP-Q-SF, the three greatest fears were: Item 10 'Worrying that medications could damage the body', Item 1 'Being afraid of disease progression' and Item 2 'Being nervous prior to doctors' appointments or periodic examinations'. About 68.4% of patients reported the dysfunctional level of fear of progression. Multiple linear regression analysis showed that religious belief, family income, disease stages, social support, QOL were identified as independent predictors for FCR.
We found that FCR is prevalent in postoperative breast cancer patients, and is influenced by many factors. It is necessary to implement positive intervention measures to alleviate the FCR and improve the QOL of patients.
确定乳腺癌患者术后癌症复发恐惧(FCR)的特征,并调查FCR与人口统计学和医学特征、生活质量(QOL)及社会支持之间的关系。
对342例接受手术治疗的乳腺癌患者进行了简化版的疾病进展恐惧问卷(FoP-Q-SF)、乳腺癌患者癌症治疗功能评估(FACT-B)和社会支持评定量表调查。进行分析以确定与FCR相关的潜在预测因素。
465例患者中,342例(73.5%)同意参与研究。参与者的平均年龄为51.46±10.50岁(范围30 - 81岁)。342例参与者中,92例(26.9%)为Ⅰ期,131例(38.3%)为Ⅱ期,34例(9.9%)为Ⅲ期,85例(24.9%)为Ⅳ期。在FoP-Q-SF的12个项目中,三大恐惧分别为:第10项“担心药物会损害身体”、第1项“害怕疾病进展”和第2项“在预约医生或定期检查前感到紧张”。约68.4%的患者报告有功能失调性的疾病进展恐惧。多元线性回归分析显示,宗教信仰、家庭收入、疾病分期、社会支持、生活质量被确定为FCR的独立预测因素。
我们发现FCR在乳腺癌术后患者中普遍存在,且受多种因素影响。有必要采取积极的干预措施来减轻FCR并提高患者的生活质量。